DNTH dianthustx.com Operating Profitability

Public company logo of Dianthus Pharma (DNTH)

Dianthus Therapeutics (DNTH) has earned its status as a promising biotech firm due to the scientific authority of its leadership. However, the lack of sales and dependence on R&D create significant risks. The operating margin tracker clearly demonstrates financial volatility, where -8683.90 represents the latest metric reading. Business stability is supported by strategic alliances aimed at creating innovative antibodies to combat inflammation.

DNTH - dianthustx.com Operating Profit Ratio over the range 02/21/2024 - 11/20/2026

Analytical breakdowns and data insights for company dianthustx.com (DNTH)

- share price and consensus valuation forecast:
Initial company analysis:Dianthus Pharma
Brand item of Dianthus Therapeutics

Operating margin determines the portion of revenue remaining after all production and administrative expenses are paid. This ratio allows for an assessment of cost management efficiency and the internal profitability of the business. By analyzing changes in core operating margins, an investor can identify the real potential for profit scaling. For Dianthus Therapeutics (DNTH), this indicator confirms strong pricing power driven by unique antibodies. Inelastic demand for the drugs provides the company with a sustainable competitive advantage.

Competitor analysis for Dianthus Therapeutics

ARGX (argenx N.V.) - Operating Margin|Operating Return on Sales BioNTech Pharma BNTX|Operating Sales Margin ABVX (ABIVAX)|Operating Margin ADMA Biologics, Inc. (ADMA)|Operating Margin PTGX (protagonist-inc.com)|IMVT: Return on Sales by Operating Profit|KNSA - Operating Profitability|GRFS: Operating Profitability|ADPT (Adaptive Biotechnologies) - Operating Sales Margin|Return on Sales by Operating Profit CLDX|Operating Sales Margin AUPH|BCRX (BioCryst Pharmaceuticals) - Operating Profit Ratio|Operating Profitability Vera Pharma (VERA)|Profitability of Operations Pharvaris N.V.|AbCellera Biologics Inc - Operating Sales Margin|Tourmaline Bio (TRML) - Operating Return on Sales|PGEN - Operating Profitability|Operating Profit Rate PHAR (Pharming Group NV)|NKTR: Operating Margin|Upstream Bio Corp - Operating Profit Rate|Operating Profitability Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Profitability of Operations|Operating Margin GOSS|Operating Sales Margin KalVista Pharmaceuticals, Inc. KALV|Operating Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Operating Return on Sales|SVRA - Operating Profitability|Rigel Pharmaceuticals - Operating Profit Ratio|AnaptysBio Corp (ANAB) - Operating Profitability|ATXS - Profitability of Operations|Operating Profitability enGene Holdings Inc.|RAPT: Operating Profit Rate|Operating Margin JBIO|Operating Sales Margin aclaristx.com ACRS|Operating Profitability Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Operating Return on Sales|Cabaletta Bio, Inc - Operating Margin|Operating Return on Sales Ventyx Biosciences|THTX (theratech.com) - Operating Sales Margin|Operating Sales Margin Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Operating Margin|Operating Return on Sales Agenus Inc. AGEN|Operating Sales Margin CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Operating Profit Rate|Operating Profitability atyrpharma.com ATYR|Operating Margin Adagene Corp ADAG|IMA - Operating Profitability|Operating Profit Rate STTK (Shattuck Labs)|EQ: Operating Margin|Connect Biopharma (CNTB) - Operating Margin|Operating Profitability Immunic|Operating Margin atarabio.com|Operating Margin IFRX|Operating Margin X4 Pharma (XFOR)|Operating Margin ACET (adicetbio.com)|Operating Margin Celularity Inc. CELU|INMB - Operating Profitability|Operating Profit Rate BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Operating Sales Margin|Operating Sales Margin SAB Biotherapeutics Inc.|Operating Sales Margin AKTX|Operating Sales Margin enlivex.com (ENLV)|Operating Profitability Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operating Profitability Margin|Operating Margin EDSA (Edesa Biotech Corp)|Profitability of Operations iBio (IBIO)|CARM - Operating Profitability|XTL Biopharmaceuticals (XTLB) - Operating Sales Margin|BOLT: Operating Margin|Operating Sales Margin HCW Biologics Inc.|Operating Profitability Aptevo|Return on Sales by Operating Profit AIM (AIM ImmunoTech, Inc.)|Operating Margin ADTX|Profitability of Operations GRI Bio Corp|Operating Margin XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Operating Return on Sales|Revelation Biosciences Corp - Operating Margin|INDP (Indaptus Therapeutics, Inc.) - Return on Sales by Operating Profit|SCNI: Operating Margin|CALI - Profitability of Operations|AFMD (Affimed N.V.) - Operating Margin|Operating Profitability ALLK|Operating Sales Margin HOOK (HOOKIPA Pharma, Inc.)|IGMS - Operating Return on Sales|Operating Profitability iTeos ITOS|Ocean Bio - Operating Profitability|TC BioPharm Ltd - Operating Margin|Operating Return on Sales thirdharmonicbio.com